Hepatitis B virus mutations in the pre-S genome before and after liver transplantation

Hepatology

Volumn 24, Issue 3, 1996, Pages 482-488

  Trautwein, Christian ^a   Schrem, Harald ^a   Tillmann, Hans L ^a   Kubicka, Stefan ^a   Walker, Diana ^a   Böker, Klaus H W ^b   Maschek, Hans Jörg ^a   Pichlmayr, Rudolph ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; GENE DELETION; GENE INSERTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROMOTER REGION; REINFECTION; VIRUS GENOME; VIRUS MUTATION;

EID: 0029795137     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781311     Document Type: Article

References (46)

1. Samuel D, Bismuth H. Liver transplantation for hepatitis B. Gastroenterol Clin North Am 1993;22:271-283.
2. Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1990;103:1307-1312.
3. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Sarzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. HEPATOLOGY 1991;13:619-626.
4. Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzl TE, van Thiel DH. Incidence, prevalence, and clinical course of hepatitis B following liver transplantation. Gastroenterology 1992;103:323-329.
5. Lauchert W, Müller R, Pichlmayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987;19:2387-2389.
6. Müller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, et al. Liver transplantation in Hbs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunisation. J Hepatol 1991;13:90-96.
7. Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, Brechot C, et al. Passive immunoprophylaxis after liver transplantation in HBsAg positive patients. Lancet 1991;337:813-815.
8. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988;69: 2575-2583.
9. Carman WF, Thomas H, Esteban D. Viral genetic variation: hepatitis B as a clinical example. Lancet 1993;341:349-352.
10. Milich DR, Thornton GB, Neurath A, Kent S, Michel M, Tiollais P, Chisari FV. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 1985;228:1195-1199.
11. Milich DR, McNamara MK, McLachlan A, Thornton GB, Chisari FV. Distinct H-2-linked regulation of T-cell responses to the PreS and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. Proc Natl Acad Sci U S A 1985;82: 8168-8172.
12. Milich DR, McLachlan A, Chisari FV, Nakamura T, Thornton GB. Two distinct but overlapping antibody binding sites in the PreS(2) region of HBsAg localized within 11 continuous residues. J Immunol 1986;137: 2703-2710.
13. Milich DR, McLachlan A, Chisari FV, Kent SBH, Thornton GB. Immune response to the PreS(1) region of the hepatitis B surface antigen (HBsAg): a preS(1)-specific T cell response can bypass nonresponsiveness to the preS(2) and S regions of HBsAg. J Immunol 1986;137:315-322.
14. Neurath AR, Kent SBH, Strick N, Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986;46:429-436.
15. Neurath AR, Kent SBH, Parker K, Prince AM, Strick N, Brotman B, Sproul P. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine 1986;4: 35-37.
16. Neurath AR, Strick N, Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med 1992;175:461-469.
17. Lu CC, Chen M, Ou JH, Yen TSB. Key role of a CCAAT element in regulating hepatitis B virus surface protein expression. Virology 1995;206:1155-1158.
18. Gerken G, Kremsdorf D, Capel F, Dauguet C, Manns M, Meyer zum Büschenfelde K-H, Brechot C. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV-infection. Virology 1991;183: 555-565.
19. Santantonio T, Jung MC, Schneider R, Fernholz D, Milella M, Monno M, Pastore G, et al. Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occus frequently and as a dominant virus population in chronic carriers in Italy. Virology 1992;188:948-952.
20. Böker KH, Ringe B, Krüger M, Pichlmayr R, Manns MP. Prostaglandin E plus famciclovir - a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994;57:1706-1708.
21. Michitaka K, Durrazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology 1994;106:1603-1610.
22. Tillmann HL, Trautwein C, Walker D, Kubicka S, Böker K, Manns M. Prevalence of the hepatitis B e-minus variant in northern Europe. Gut 1995;37:568-573.
23. Kubicka S, Trautwein C, Schrem H, Tillmann H, Manns MP. Hepatocellular carcinoma and P53 mutation in northern Europe. J Hepatol 1995;23: 412-419.
24. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev 1990;4:1541-1551.
25. Trautwein C, Walker D, Plümpe J, Manns MP. Transactivation of LAP/ NF-IL6 is mediated by an acidic domain in the N-terminal part of the protein. J Biol Chem 1995;270:15130-15136.
26. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charny P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979;281:646-650.
27. Valenzuela P, Quiroga M, Zalvidar J, Gray P, Rutter WJ. The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In: Fields BN, Jaenisch R, Fox CF, eds. Animal virus genetics: New York: Academic Press, 1980:57-70.
28. Kobayashi M, Koike K. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene 1984;30: 227-232.
29. Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizuka H, Gotanda T, Tsuda F, et al. Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol 1986;67:2305-2314.
30. Mimms LT, Floreani M, Tyner J, Whitters E, Rosenlof R, Wray L, Goetze A, et al. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the preS1 and preS2 domains of the viral envelope. Virology 1990;176:604-619.
31. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, et al. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A 1986;83:9174-9178.
32. Neurath AR, Thanavala Y. Hepadnaviruses. In: Van Regenmortel MHV, Neurath AR, eds. Immunochemistry of Viruses II. Amsterdam: Elsevier, 1990:403-458.
33. Petit MA, Dubanchet S, Capel F, Voet P, Dauguet C, Hauser P. HepG2 cell binding activities of different hepatitis B isolates: inhibitory effect of anti-HBs and anti-preS (21-47). Virology 1991;180:483-491.
34. Petit MA, Strick N, Dubanchet S, Capel F, Neurath AR. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands. Mol Immunol 1991;28:517-521.
35. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-S sequence. J Virol 1994;52:396-402.
36. Zhou D-X, Yen TSB. The hepatitis B virus S promoter comprises a CCAAT motif and two initiation regions. J Biol Chem 1991;266:23416-23421.
37. Kozak M. The scanning model for translation: an update. J Cell Biol 1989; 108:229-241.
38. Milich DR, Jones JE, McLachlan A, Bitter G, Moriarty A, Hughes JL. Importance of subtype in the immune response to the preS(2) region of the hepatitis B surface antigen II. Synthetic PreS(2) immunogen. J Immunol 1990;144:3544-3551.
39. Lau J, Bain VG, Davies SE, O'Grady JG, Alberti A, Alexander GJM, Williams R. High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992;102:956-962.
40. Samuel D, Müller R, Alexander G, Fassati L, Ducot B, Benhamou J-P, Bismuth H, and the investigators of the European Concerted Action on Viral Hepatitis study. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
41. Indications for liver transplantation. Text of a consensus conference. Ann Gastroenterol Hepatol (Paris) 1994;30:101-104, 109-112.
42. Grellier L, Brown D, Berenek P, Rolles K, Burroughs A, Dusheiko G. Lamivudine prophylaxis: a new strategy for prevention of hepatitis B reinfection in liver transplantation for hepatitis B DNA positive cirrhosis. Single topic symposium on liver transplantation for chronic viral hepatitis. Reston, VA, 1995.
43. Krüger M, Tillmann HL, Trautwein C, Bode U, Oldhafer K, Böker KHW, Pichlmayr R, et al. Treatment of hepatitis B virus reinfection after liver transplantation with famciclovir. HEPATOLOGY 1994;20:130A.
44. Carman FW, Trautwein C, van Deursen FJ, Colman K, McIntyre G, Kliem V, Waters J, et al. Hepatitis B virus envelope variation after transplantation with and without polyclonal antibody pressure. HEPATOLOGY 1994; 20:138A.
45. Robinson WS. Hepadnaviridae and their replication. In: Fundamental virology, 2nd ed. Fields-BN, Knipe-DM, eds. New York: Raven Press, 1991: 989-1021.
46. Raney AK, Millich DR, McLachlan A. Characterization of hepatitis B virus major surface antigen gene transcriptional regulatory elements in differentiated hepatoma cell lines. J Virol 1989;63:3919-3925.